Impact of Preoperative Breast MRIs on Timing of Surgery and Type of Intervention in Newly Diagnosed Breast Cancer Patients

By Angarita Fernando   Acuna Sergio   Fonseca Adriana   Crystal Pavel   Escallon Jaime  

Annals of Surgical Oncology, Vol. 17, Iss. 3, 2010-10 ,pp. : 273-279

Springer Publishing Company

Access to resources Recommend Favorite

Prediction of the Need for Red Cell Transfusion in Newly Diagnosed Ovarian Cancer Patients Undergoing Platinum-Based Treatment

By Heddens D.   Alberts D.S.   Hannigan E.V.   Williams S.D.   Garcia D.   Roe D.J.   Bell J.   Alvarez R.D.  

Gynecologic Oncology, Vol. 86, Iss. 3, 2002-09 ,pp. : 239-243

Academic Press

Access to resources Recommend Favorite

Phase I Study of Alternating Doublets of Topotecan/Carboplatin and Paclitaxel/Carboplatin in Patients with Newly Diagnosed, Advanced Ovarian Cancer

By Gordon A.N.   Hancock K.C.   Matthews C.M.   Messing M.   Stringer C.A.   Doherty M.G.   Teneriello M.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 129-135

Elsevier

Access to resources Recommend Favorite

Systematic Review of First-Line Chemotherapy for Newly Diagnosed Postoperative Patients with Stage II, III, or IV Epithelial Ovarian Cancer

By Covens A.   Carey M.   Bryson P.   Verma S.   Fung Kee Fung M.   Johnston M.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 71-80

Elsevier

Access to resources Recommend Favorite

Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer

By Miller Brigitte  

The Women's Oncology Review, Vol. 5, Iss. 3, 2005-09 ,pp. : 159-160

Informa Healthcare

Access to resources Recommend Favorite